RPL31 and Alzheimer disease: Additionally, we found that the mRNA expression levels of RPL31, PSMA6 and COX7A2 in the AD samples were higher than those in MCI samples (p = 0.042, 0.035 and 0.020; Dunn’s test) (Fig. 6 and Supplementary Data 10).